Filing Details
FATE THERAPEUTICS INC (NASDAQ:FATE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:FATE
FATE THERAPEUTICS INC (FATE) Files Quarterly Report for Q0
FATE THERAPEUTICS INC (NASDAQ:FATE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
FATE THERAPEUTICS INC (NASDAQ:FATE) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- FATE Therapeutics filed its quarterly report (Form 10-Q) on August 13, 2026, providing unaudited financial statements and management commentary on recent business performance.
- The company's stock trades at $2.52 with a market capitalization of $128.0 million as of the filing date.
- The quarterly report includes updated risk factors and information about emerging trends and changes in business conditions since the previous filing.
Market Context
FATE THERAPEUTICS INC's stock currently trades at $2.52 with a market capitalization of $128.0M.
The 10-Q provides FATE THERAPEUTICS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for FATE THERAPEUTICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View FATE Stock Page
Frequently Asked Questions
Where can I read FATE's SEC filings?
Browse all filings on our FATE SEC filings page.
What types of SEC filings does FATE THERAPEUTICS INC file?
Public companies like FATE THERAPEUTICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.